Position
EVOLVE PRIVATE WEALTH, LLC in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$293.8K$46.30 → $33.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 22.2K | $1.03M | — | — | — | 0.1% |
| Q1 2026 | 23.5K | $777.8K | $33.07 | −$293.8K | $43.4K | 0.0% |